Delivery Order SPE2DB22D1017-SPE2DB24FF3LY
Award Date
2/29/24
Potential Completion Date
3/1/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply DUPIXENT 300 MG/2 ML PEN 2ML medical products. The $35,276.49 award has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,125.02 contract is for the provision of 4557208769 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceuticals. The award, valued at $5,921.36, has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with any set-aside program. This delivery order is issued under a larger indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $5,542.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4564155597 DUPIXENT 300 MG/2 ML PEN 2ML, with an ultimate completion date of April 4, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $3,885.26 to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not associated with any set-aside program. This delivery order is issued under a larger indefinite delivery contract...
The Defense Logistics Agency (DLA) awarded a $3,304.72 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply DUPIXENT 300 MG/2 ML PEN 2ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of medications and healthcare...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $13,655.88 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,184,849 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. The IDC enables Amerisourcebergen to deliver a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,205,110 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The delivery order, valued at $26,135.63, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA that serves as the primary contract vehicle for the company to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The $13,218.88 contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) with a maximum value of $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $38,700.68 to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 and running through December 2025,...